Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents

Blood

Volumn 114, Issue 23, 2009, Pages 4771-4776

  Wang, Zhao Yang ^a   Li, Ye Xiong ^a   Wang, Wei Hu ^a   Jin, Jing ^a   Wang, Hua ^a   Song, Yong Wen ^a   Liu, Qing Feng ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Qi, Shu Nan ^a   Fang, Hui ^a   Liu, Xin Fan ^a   Yu, Zi Hao ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; NK T CELL LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; CHINA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NOSE TUMOR; PATHOLOGY; PHARYNX CANCER; REMISSION; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHINA; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; NEOPLASM STAGING; NOSE NEOPLASMS; PHARYNGEAL NEOPLASMS; PREDNISONE; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 74049105291     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-235853     Document Type: Article

References (40)

1. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-4130.
2. Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 2001;15(7):1123-1126.
3. Avilés A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol. 2000;22(4):215-220.
4. Barrionuevo C, Zaharia M, Martinez MT, et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol. 2007;15(1):38-44.
5. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83(3):449-456.
6. Bossard C, Belhadj K, Reyes F, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2007;109(5):2183-2189.
7. Huang MJ, Jiang Y, Liu WP, et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys. 2008;70(1):166-174.
8. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer. 2004;100(2):366-375.
9. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004;103(1):216-221.
10. Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal NK/T-cell lymphoma. J Clin Oncol. 2006;24(1):181-189.
11. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002;54(1):182-190.
12. Meadows AT, Sposto R, Jenkin RD, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin lymphoma of children: a report from the Childrens Cancer Study Group. J Clin Oncol. 1989;7(1):92-99.
13. Laver JH, Kraveka JM, Hutchison RE, et al. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group Phase III trial. J Clin Oncol. 2005;23(3):541-547.
14. Hwang IG, Yoo KH, Lee SH, et al. Clinicopathologic features and treatment outcomes in malignant lymphoma of pediatric and young adult patients in Korea: comparison of Korean all-ages group and Western younger age group. Clin Lymphoma Myeloma. 2007;7(9):580-586.
15. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer. 2005;41(10):1402-1408.
16. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24(4):612-618.
17. Kim TM, Lee SY, Jeon YK, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol. 2008;19(8):1477-1484.
18. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2009;113(17):3931-3937.
19. Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood. 2008;112(8):3057-3064.
20. Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res. 2009;15(8):2905-2912.
21. Brodkin DE, Hobohm DW, Nigam R. Nasal-type NK/T-cell lymphoma presenting as hemophagocytic syndrome in an 11-year-old Mexican boy. J Pediatr Hematol Oncol. 2008;30(12):938-940.
22. Lee JY, Jang YD, Kim HK. The primary role of the otolaryngologist in managing pediatric sinonasal malignancies: an extranodal NK/T-cell lymphoma originating from the inferior turbinate mucosa of the nasal cavity. J Pediatr Hematol Oncol. 2008;30(5):401-404.
23. Hutchison RE, Laver JH, Chang M, et al. Nonanaplastic peripheral T-cell lymphoma in childhood and adolescence: a Children's Oncology Group study. Pediatr Blood Cancer. 2008;51(1):29-33.
24. Aydin GB, Akyuz C, Talim B, et al. Extranodal type T/NK-cell lymphoma with an atypical clinical presentation. Pediatr Hematol Oncol. 2007;24(4):291-299.
25. Pol-Rodriguez MM, Fox LP, Sulis ML, et al. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh. J Am Acad Dermatol. 2006;54(5 suppl):S192-S197.
26. Shaw PH, Cohn SL, Morgan ER, et al. Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literature. Cancer. 2001;91(4):642-646.
27. Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:285-288.
28. Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329(14):987-994.
29. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol. 1999;17(4):1244-1253.
30. Serrano-Olvera A, Gerson R. Age associated survival rate in non-small cell lung cancer. Gac Med Mex. 2009;145(1):27-35.
31. Gnerlich JL, Deshpande AD, Jeffe DB, et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208(3):341-347.
32. You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004;15(4):618-625.
33. Pan ZH, Huang HQ, Lin XB, et al. Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma: a report of 93 cases. Ai Zheng. 2005;24(12):1493-1497.
34. Yang Y, Zhang YJ, Lin XB, et al. Role of radiotherapy in the treatment of patients with early stage extranodal nasal-type NK/T-cell lymphoma and analysis of prognostic factors. Chin J Radiat Oncol. 2009;18(4):285-289.
35. Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol. 2001;61(3):261-269.
36. Kim TM, Park YH, Lee SY, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood. 2005;106(12):3785-3790.
37. Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24(13):1990-1996.
38. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25(31):4873-4879.
39. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensitymodulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085-2092.
40. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009;10(3):258-266.